Navigation Links
TECNALIA investigates advanced biomaterials to make more reliable and hardwearing medical implants
Date:11/12/2008

The TECNALIA Technological Corporation is taking part in the Cnit Intelimplant project, the goal of which is to develop advanced biomaterials based on innovative technologies (microtechnologies, nanotechnologies, tissue and surface engineering) for the manufacture of a new generation of implants which have greater durability and reliability, need less recuperation time and that provide data on their state and progress.

The Cnit Intelimplant project (Development of Advanced Biomaterials for a New Generation of Implants), led by the Biotechnology Institute (BTI), was one of the 16 projects approved by the Centre for Industrial Technological Development (CDTI) for the third CNIT programme announcement or call, within the Spanish Government INGENIO 2010 initiative.

The end goal of the project is the development of novel biomaterials which enable an extension of the functions of the implant throughout the whole life of the patient, in such a way that repeat surgical operations are avoided; the reliability and the integration of the implants are enhanced and tissue rejection avoided; the recuperation times for patients are significantly cut and the implants are operational in a minimum time; the state and progress of the implant monitored, both in the short term and in the long term after the surgical operation; the new materials will indicate any anomaly and enable the application of preventative therapies; and finally, they will simplify surgical practice, progressing to minimally invasive surgery and the automation of stages during an operation.

The project will be undertaken by a consortium made up of 15 companies, including state-of-the-art Spanish enterprises in the field of implants, BTI Biotechnology Institute, SURGIVAL, LAFITT, SOCINSER and IHT, as well as the most important ones in the value chain of their manufacture: KERAMAT, Laboratories INIBSA, BIOKER Research, METAL-ESTALKI, BIOVAC, DMP, i2m-DESIGN, ANLISIS & SIMULACIN (AyS), IHS WEIGLING and GEM-IMAGING.

The Intelimplant project involves groups belonging to 16 public and private research bodies: TECNALIA, the Institute of Biomechanics of Valencia-IBV, the Institute of Polymers Science and Technology (ICTP-CSIC), the University of Len, the University of Vigo, the University of Mlaga, the National Microelectronics Centre (CNM-CSIC), the Institute for Corpuscular Physics (IFIC-CSIC), the Institute of Ceramica Galicia, the Polytechnic University of Catalunya (UPC), PRODINTEC, INCAR, ICMM-CSIC, the University of Barcelona, the Bosch i Gimpera Foundation and the Chemical Institute of Sarri (IQS).

Carrying out this project will also enable fomenting synergies and reducing project development times through drawing up a joint-working framework between the various multidisciplinary players within the Science-Technology-Enterprise network. These players have knowledge and experience that complement each other and which are present throughout the whole value chain of the sector and, as a consequence, will give rise to enhanced competitiveness amongst the participating companies, thus reducing excessive external dependence, readdressing the unfavourable situation of our country as regards the transfer of research results by OPIs and CITs to companies in this field of advanced biomaterials, and improving the scientific-technical level of the enterprises taking part in the project. All this with the target of being in a more advantageous position to participate in international programmes of cooperation in scientific research and technological development, such as the FP VII.


'/>"/>

Contact: Irati Kortabitarte
iratik@elhuyar.com
34-943-363-040
Elhuyar Fundazioa
Source:Eurekalert

Related biology news :

1. TECNALIA leads five projects within the VII Framework Program
2. Queens marine biologist investigates aliens beneath the waves
3. Selexis Announces Advanced Approach to Maximize Power of Genetic Elements for Rapid Development of High Performance Cell Lines
4. Embryonic stem cell strategy advanced with UCSF finding
5. Model for the assembly of advanced, single-molecule-based electronic components developed at Pitt
6. $1.1 million NSF grant to fund research in advanced light microscopy at UCLA
7. CSIC and UAB will build the most advanced superconductor cable for electricity network
8. Research at Argonnes Advanced Photon Source reveals structure and behavior of collagen
9. Eribulin mesylate demonstrated anti-tumor activity in patients with advanced breast cancer
10. Experimental chemotherapy regimen shows promise in treating advanced lung cancer
11. Combining advanced medical and information technologies offers pathway to lower health care costs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/11/2017)... 2017 NXT-ID, Inc. (NASDAQ:   NXTD ... the appointment of independent Directors Mr. Robin D. Richards ... of Directors, furthering the company,s corporate governance and expertise. ... Gino Pereira , Chief ... to their guidance and benefiting from their considerable expertise as ...
(Date:4/5/2017)... 5, 2017  The Allen Institute for Cell Science ... a one-of-a-kind portal and dynamic digital window into the ... the first application of deep learning to create predictive ... lines and a growing suite of powerful tools. The ... and future publicly available resources created and shared by ...
(Date:4/5/2017)... LONDON , April 4, 2017 KEY ... is anticipated to expand at a CAGR of 25.76% ... neurodegenerative diseases is the primary factor for the growth ... full report: https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The ... of product, technology, application, and geography. The stem cell ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... 11, 2017 , ... ComplianceOnline’s Medical Device Summit is back for its 4th ... in San Francisco, CA. The Summit brings together current and former FDA office bearers, ... and government officials from around the world to address key issues in device compliance, ...
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. ... Cancer Research, London (ICR) and University ... SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma ... MUK nine . The University of Leeds ... partly funded by Myeloma UK, and ICR will perform the ...
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... ... Administration (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal ... the treatment of osteosarcoma. SBT-100 is able to cross the cell membrane and ...
(Date:10/10/2017)... , ... October 10, 2017 , ... ... Center’s FirstHand program has won a US2020 STEM Mentoring Award. Representatives of the ... for Excellence in Volunteer Experience from US2020. , US2020’s mission is to change ...
Breaking Biology Technology: